期刊
ANNALS OF PHARMACOTHERAPY
卷 44, 期 7-8, 页码 1330-1333出版社
SAGE PUBLICATIONS INC
DOI: 10.1345/aph.1P078
关键词
Arepanrix; Guillain-Barre syndrome; H1N1 vaccine
OBJECTIVE: To report a case of Guillain-Barre syndrome (GBS) following a dose of influenza A (H1N1) vaccine (Arepanrix). CASE SUMMARY: An 11-year-old boy was admitted to the hospital after presenting with facial diplegia; abdominal, forehead, and thigh pain; and acute cervical pain. He had received the Arepanrix H1N1 subcutaneous vaccine 13 days before symptom onset. The neurologic examination also revealed a symmetric bilateral paralysis of the VIIth cranial nerve and intense pain, proximal weakness of the shoulder girdles and pelvis, and preserved deep tendon reflexes. Cerebrospinal fluid analysis revealed an albuminocytologic dissociation. Therefore, a diagnosis of atypical GBS following vaccination against H1N1 influenza was made. DISCUSSION: Based on the clinical evaluation, laboratory test results, neurologic features, and the exclusion of alternative diagnoses, the Naranjo probability scale revealed a probable relationship between the clinical manifestations of GBS and the vaccine against influenza A (H1N1) received by the patient. This is the first published case for the 2009 influenza pandemic in children. CONCLUSIONS: While recent studies have found inconclusive results on the association between influenza vaccine and GBS, all suspected cases should be published for further evaluation.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据